Effects of angiotensin II receptor blockers on serum potassium level and hyperkalemia risk: retrospective single-centre analysis.

Sakae Fukushima, Manami Oishi,Hiroya Aso, Kifumi Arai, Yuuki Sasaki,Naohiro Tochikura,Susumu Ootsuka,Noriyasu Fukuoka,Nobuhiro Ooba,Norikazu Kikuchi

European journal of hospital pharmacy : science and practice（2021）

引用 0|浏览1

暂无评分

摘要

The increase in serum potassium level after ARB initiation makes it necessary to monitor serum potassium levels continuously during ARB treatment; however, the risk of hyperkalaemia appeared to be similar for ARB and CCB treatments.

查看译文

关键词

clinical medicine,drug monitoring,drug-related side effects and adverse reactions,hospital,pharmacy administration,pharmacy service

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要